The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Arctigenin protects against depression by inhibiting microglial activation and neuroinflammation via HMGB1/TLR4/NF‐κB and TNF‐α/TNFR1/NF‐κB pathways
Open accessAbstract
Background and Purpose: Arctigenin, a major bioactive component of Fructus arctii, has been reported to have antidepressant‐like effects. However, the mechanisms underlying these effects are still unclear. Neuroinflammation can be caused by excessive production of proinflammatory cytokines in microglia via high‐mobility group box 1 (HMGB1)/TLR4/NF‐κB and TNF‐α/TNFR1/NF‐κB signalling pathways, leading to depression. In this study, we have investigated the antidepressant mechanism of arctigenin by conducting in vitro and in vivo studies. Experimental Approach: The effects of chronic unpredictable mild stress (CUMS) on wild‐type (WT) and TLR4−/− mice were examined. Antidepressant‐like effects of arctigenin were tested using the CUMS‐induced model of depression in WT mice. The effects of arctigenin were assessed on the HMGB1/TLR4/NF‐κB and TNF‐α/TNFR1/NF‐κB signalling pathways in the prefrontal cortex (PFC) of mouse brain and HMGB1‐ or TNF‐α‐stimulated primary cultured microglia. The interaction between HMGB1 and TLR4 or TNF‐α and TNFR1 with or without arctigenin was examined by localized surface plasmon resonance (LSPR) and co‐immunoprecipitation assays. Key Results: The immobility times in the tail suspension test (TST) and forced swimming test (FST) were reduced in TLR4−/− mice, compared with WT mice. Arctigenin exhibited antidepressant‐like effects. Arctigenin also inhibited microglia activation and inflammatory responses in the PFC of mouse brain. Arctigenin inhibited HMGB1 and TLR4 or TNF‐α and TNFR1 interactions, and suppressed both HMGB1/TLR4/NF‐κB and TNF‐α/TNFR1/NF‐κB signalling pathways. Conclusions and Implications: Arctigenin has antidepressant‐like effects by attenuating excessive microglial activation and neuroinflammation through the HMGB1/TLR4/NF‐κB and TNF‐α/TNFR1/NF‐κB signalling pathways. This suggests that arctigenin has potential as a new drug candidate suitable for clinical trials to treat depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Fan, C., Song, Q., Wang, P., Li, Y., Yang, M., & Yu, S. Y. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02889 · Cited by 111
RetractedTrott, O., & Olson, A. J. (2010) · Journal of Computational Chemistry · doi:10.1002/jcc.21334 · Cited by 38,412
AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009) · Journal of Computational Chemistry · doi:10.1002/jcc.21256 · Cited by 25,486
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., Rush, A. J., Walters, E. E., & Wang, P. S. (2003) · JAMA · doi:10.1001/jama.289.23.3095 · Cited by 7,988
The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research
Percie du Sert, N., Hurst, V., Ahluwalia, A., Alam, S., Avey, M. T., Baker, M., Browne, W. J., Clark, A., Cuthill, I. C., Dirnagl, U., et al. (2020) · PLOS Biology · doi:10.1371/journal.pbio.3000410 · Cited by 5,939
The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research
Percie du Sert, N., Hurst, V., Ahluwalia, A., Alam, S., Avey, M. T., Baker, M., Browne, W. J., Clark, A., Cuthill, I. C., Dirnagl, U., et al. (2020) · Experimental Physiology · doi:10.1113/ep088870 · Cited by 3,497
HMG-1 as a Late Mediator of Endotoxin Lethality in Mice
Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J. M., Ombrellino, M., Che, J., Frazier, A., Yang, H., Ivanova, S., Borovikova, L., et al. (1999) · Science · doi:10.1126/science.285.5425.248 · Cited by 3,385
Python: a programming language for software integration and development.
Sanner, M. F. (1999) · PubMed · Cited by 3,093
Willner, P., Towell, A., Sampson, D., Sophokleous, S., & Muscat, R. (1987) · Psychopharmacology · doi:10.1007/bf00187257 · Cited by 1,993
Signal transduction by tumor necrosis factor and its relatives
Baud, V., & Karin, M. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)02064-5 · Cited by 1,655
Curtis, M. J., Alexander, S., Cirino, G., Docherty, J. R., George, C. H., Giembycz, M. A., Hoyer, D., Insel, P. A., Izzo, A. A., Ji, Y., et al. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14153 · Cited by 1,338 · cited 1×
“The data and statistical analysis comply with the recommendations of the British Journal of Pharmacology on experimental design and analysis in pharmacology (Curtis et al., 2018).”
MethodARRIVE 2.0 and the British Journal of Pharmacology: Updated guidance for 2020
Lilley, E., Stanford, S. C., Kendall, D. E., Alexander, S. P. H., Cirino, G., Docherty, J. R., George, C. H., Insel, P. A., Izzo, A. A., Ji, Y., et al. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15178 · Cited by 1,214
Kang, R., Chen, R., Zhang, Q., Hou, W., Wu, S., Cao, L., Huang, J., Yu, Y., Fan, X.-G., Yan, Z., et al. (2014) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2014.05.001 · Cited by 956
Depression as a Microglial Disease
Yirmiya, R., Rimmerman, N., & Reshef, R. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2015.08.001 · Cited by 944
Alexander, S. P. H., Roberts, R. E., Broughton, B. R. S., Sobey, C. G., George, C. H., Stanford, S. C., Cirino, G., Docherty, J. R., Giembycz, M. A., Hoyer, D., et al. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14112 · Cited by 891
Yang, H., Hreggvidsdottir, H. S., Palmblad, K., Wang, H., Ochani, M., Li, J., Lu, B., Chavan, S., Rosas-Ballina, M., Al-Abed, Y., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003893107 · Cited by 809
Self-citationTolerance, DCs and tryptophan: much ado about IDO
Grohmann, U. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(03)00072-3 · Cited by 766
Brites, D., & Fernandes, A. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00476 · Cited by 599 · cited 1×
“The pathogenesis of depression has been related to the neuroinflammation caused by the activation of microglia in the brain (Brites & Fernandes, 2015; Yirmiya, Rimmerman, & Reshef, 2015) and excessive neuroinflammatory reactions have been shown to lead to neuronal damage in the PFC of CUMS-induced…”
BackgroundTNF and its receptors in the CNS: The essential, the desirable and the deleterious effects
Probert, L. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.06.038 · Cited by 495
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Introduction and Other Protein Targets
Alexander, S. P. H., Kelly, E., Mathie, A., Peters, J. A., Veale, E. L., Armstrong, J. F., Faccenda, E., Harding, S. D., Pawson, A. J., Sharman, J. L., et al. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14747 · Cited by 423
Pan, Y., Chen, X.-Y., Zhang, Q.-Y., & Kong, L.-D. (2014) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2014.04.007 · Cited by 405
Guo, L.-T., Wang, S.-Q., Su, J., Xu, L.-X., Ji, Z.-Y., Zhang, R.-Y., Zhao, Q.-W., Ma, Z.-Q., Deng, X.-Y., & Ma, S.-P. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1474-8 · Cited by 401
Lee, J., Ryu, H., Ferrante, R. J., Morris, S. M., & Ratan, R. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0735876100 · Cited by 358
Depressive-like behavior induced by tumor necrosis factor-α in mice
Kaster, M. P., Gadotti, V. M., Calixto, J. B., Santos, A. R. S., & Rodrigues, A. L. S. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.08.018 · Cited by 294
TNFα disrupts blood brain barrier integrity to maintain prolonged depressive-like behavior in mice
Cheng, Y., Desse, S., Martinez, A., Worthen, R. J., Jope, R. S., & Beurel, E. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.02.003 · Cited by 292
Toll-like Receptors and Their Signaling Mechanisms
Akira, S., & Sato, S. (2003) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540310015683 · Cited by 265
Jiang, B., Xiong, Z., Yang, J., Wang, W., Wang, Y., Hu, Z., Wang, F., & Chen, J. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01902.x · Cited by 238
Network beyond IDO in psychiatric disorders: Revisiting neurodegeneration hypothesis
Myint, A.-M., & Kim, Y.-K. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.08.008 · Cited by 230
NLRP3 gene knockout blocks NF-κB and MAPK signaling pathway in CUMS-induced depression mouse model
Su, W.-J., Zhang, Y., Chen, Y., Gong, H., Lian, Y.-J., Peng, W., Liu, Y.-Z., Wang, Y.-X., You, Z.-L., Feng, S.-J., et al. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.01.018 · Cited by 215
Epidemiology of Major Depressive Disorder in Mainland China: A Systematic Review
Gu, L., Xie, J., Long, J., Chen, Q., Chen, Q., Pan, R., Yan, Y., Wu, G., Liang, B., Tan, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065356 · Cited by 196
Cheng, Y., Pardo, M., Armini, R. D. S., Martinez, A., Mouhsine, H., Zagury, J.-F., Jope, R. S., & Beurel, E. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.12.012 · Cited by 174
Endogenous nitric oxide decreases hippocampal levels of serotonin and dopamine in vivo
Wegener, G., Volke, V., & Rosenberg, R. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703349 · Cited by 167
Dellarole, A., Morton, P., Brambilla, R., Walters, W., Summers, S., Bernardes, D., Grilli, M., & Bethea, J. R. (2014) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2014.04.003 · Cited by 165
Yang, Q., Lu, F.-L., Zhou, Y. J., Wang, L., Zhong, Q., Lin, S., Xiang, J., Li, J., Fang, C., & Wang, J. (2010) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2010.129 · Cited by 156
Self-citationSong, T., Yang, Y., Wei, H., Xie, X., Lü, J., Zeng, Q., Peng, J., Zhou, Y., Jiang, S., & Peng, J. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz312 · Cited by 153
Leonard, B. E. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.10.018 · Cited by 129 · cited 1×
“…cytokines also increase the activity of the enzyme indoleamine 2,3-dioxygenase (IDO) resulting in depletion of 5-HT levels (Grohmann, Fallarino, & Puccetti, 2003) that are associated with depressed mood, anhedonia, sleep disturbance, anorexia, decreased libido and fatigue (Leonard, 2014).”
BackgroundRegulation of brain microglia by female gonadal steroids
Habib, P., & Beyer, C. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.02.018 · Cited by 118
Filho, A. J. M. C., Lima, C. N. D. C., Vasconcelos, S. M. M., de Lucena, D. F., Maes, M. H. J., & Macêdo, D. S. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.04.035 · Cited by 113
Anti-Depressive Effectiveness of Baicalin In Vitro and In Vivo
Liu, L., Dong, Y. J., Shan, X., Li, L., Xia, B., & Wang, H. (2019) · Molecules · doi:10.3390/molecules24020326 · Cited by 110
Wang, B., Lian, Y., Su, W., Wei, P., Dong, X. W., Liu, L.-L., Gong, H., Zhang, T., Jiang, C., & Wang, Y. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.11.017 · Cited by 109
Lian, Y., Gong, H., Wu, T., Su, W., Zhang, Y., Yang, Y., Wei, P., Zhang, T., Zhou, J., Jiang, C., et al. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.09.017 · Cited by 108
Le, K., Chibaatar, E., Wu, S., Qian, F., Ali, A. I., Yu, D., & Guo, Y. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.105779 · Cited by 106
Lü, Y., Xu, X. M., Jiang, T., Jin, L., Zhao, X., Cheng, J.-H., Jin, X., Ma, J., Piao, H., & Piao, L. X. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.12.011 · Cited by 100
Self-citationJiang, B., Wang, Y., Wang, H., Song, L., Huang, C., Zhu, Q., Wu, F., & Zhang, W. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13668 · Cited by 99
Geng, J., Liu, J., Yuan, X., Liu, W., & Guo, W. (2019) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2019.114688 · Cited by 83
Fine-tuning the central nervous system: microglial modelling of cells and synapses
Xavier, A. L. R., Menezes, J. R. L., Goldman, S. A., & Nedergaard, M. (2014) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2013.0593 · Cited by 80
Xing, Y., Mi, C., Wang, Z., Zhang, Z. H., Li, M. Y., Zuo, H. X., Wang, J. Y., Jin, X., & Ma, J. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.08.004 · Cited by 74
Self-citationMukai, Y., Shibata, H., Nakamura, T., Yoshioka, Y., Abe, Y., Nomura, T., Taniai, M., Ohta, T., Ikemizu, S., Nakagawa, S., et al. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.11.053 · Cited by 71
Shen, M., Yang, Y., Wu, Y., Zhang, B., Wu, H., Wang, L., Tang, H., & Chen, J. (2019) · Phytotherapy Research · doi:10.1002/ptr.6237 · Cited by 68
Fan, C., Song, Q., Wang, P., Li, Y., Yang, M., Liu, B., & Yu, S. Y. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.09.028 · Cited by 67
Xu, X. M., Zeng, X., Cui, Y., Li, Y.-B., Cheng, J.-H., Zhao, X., Xu, G., Ma, J., Piao, H., Jin, X., et al. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00120 · Cited by 67
Self-citationDuan, C., Zhang, J., Wan, T.-F., Wang, Y., Chen, D., & Liu, L. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112296 · Cited by 66
Chelidonine inhibits TNF‐α‐induced inflammation by suppressing the NF‐κB pathways in HCT116 cells
Zhang, Z. H., Mi, C., Wang, K. S., Wang, Z., Li, M. Y., Zuo, H. X., Xu, G. H., Li, X., Piao, L. X., Ma, J., et al. (2017) · Phytotherapy Research · doi:10.1002/ptr.5948 · Cited by 62
Self-citationGlycyrrhizic acid ameliorates the kynurenine pathway in association with its antidepressant effect
Wang, B., Lian, Y., Dong, X. W., Wei, P., Liu, L.-L., Su, W., Gong, H., Zhang, T., Jiang, C., Li, J., et al. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.01.024 · Cited by 62
Self-citationChen, B., Li, J., Xie, Y., Ming, X., Li, G., Wang, J., Li, M., Li, X., & Xiong, L. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.112088 · Cited by 62
Self-citationGuo, X., Shi, Y., Du, P., Wang, J., Han, Y., Sun, B., & Feng, J. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.117020 · Cited by 62
Chandrasekhar, Y., Ramya, E. M., Navya, K., Kumar, G. P., & Anilakumar, K. R. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.12.031 · Cited by 61
Depression and psychodynamic psychotherapy
Ribeiro, Â. D. S. B., Ribeiro, J. P., & von Doellinger, O. (2017) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2016-2107 · Cited by 61
miR-124 ameliorates depressive-like behavior by targeting STAT3 to regulate microglial activation
Lou, D., Wang, J., & Wang, X. (2019) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2019.101470 · Cited by 58
Effects of Jiaotaiwan on depressive-like behavior in mice after lipopolysaccharide administration
Qian, Z., Sulei, W., Weiwei, T., Hongyan, L., & Wang, J. (2016) · Metabolic Brain Disease · doi:10.1007/s11011-016-9925-8 · Cited by 37
Cheng, J.-H., Xu, X. M., Li, Y.-B., Zhao, X., Aosai, F., Su-yun, S., Jin, C. H., Piao, J., Ma, J., Piao, H., et al. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106302 · Cited by 36
Self-citationLi, M. Y., Zhang, Z. H., Wang, Z., Zuo, H. X., Wang, J. Y., Xing, Y., Jin, C. H., Xu, G. H., Piao, L. X., Ma, J., et al. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104355 · Cited by 35
Self-citationDou, F., Chu, X., Zhang, B., Liang, L., Lü, G., Ding, J., & Chen, S. (2018) · Molecular Brain · doi:10.1186/s13041-018-0418-z · Cited by 34
Lu, Y., Zhao, X., Xu, X. M., Piao, J. S., Aosai, F., Li, Y.-B., Shen, L.-X., Su-yun, S., Xu, G., Ma, J., et al. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106539 · Cited by 33
Self-citationRepeated arctigenin treatment produces antidepressant- and anxiolytic-like effects in mice
Du, Y., Li, W., Li, Y., Yang, J., Wang, X., Yin, S., Wang, X., de-la-Paz, O. I. V., Gao, Y., Chen, H., et al. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.12.005 · Cited by 30
Givens, C. (2016) · Nursing Clinics of North America · doi:10.1016/j.cnur.2016.01.013 · Cited by 25
Guo, Z., Zhao, F., Wang, Y., Wang, Y., Geng, M., Zhang, Y., Qing-xia, M., & Xu, X. (2019) · Journal of Molecular Neuroscience · doi:10.1007/s12031-019-01380-2 · Cited by 21
Self-citationIdentification of a microglial activation-dependent antidepressant effect of amphotericin B liposome
Gao, M., Hu, P., Cai, Z., Wu, Y. H., Wang, D., Hu, W., Xu, X., Zhang, Y.-R., Lu, X., Chen, D., et al. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.04.005 · Cited by 18
Self-citationMa, J., Mi, C., Wang, K. S., Lee, J. J., & Jin, X. (2015) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2015.10.002 · Cited by 15
Self-citationLi, D., Bao, X.-Q., Wang, X., Sun, H., & Zhang, D. (2017) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-017-1363-6 · Cited by 11
Cited by
Microglia in depression: an overview of microglia in the pathogenesis and treatment of depression
Wang, H., He, Y., Sun, Z., Ren, S., Liu, M., Wang, G., & Yang, J. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02492-0 · Cited by 571
Toll-like receptor 4: A potential therapeutic target for multiple human diseases
Wei, J., Zhang, Y., Li, H., Wang, F., & Yao, S. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115338 · Cited by 121
Neuroinflammatory basis of depression: learning from experimental models
Afridi, R., & Suk, K. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.691067 · Cited by 82
Hendawy, N., Salaheldin, T. H., & Abuelezz, S. A. (2023) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-023-10060-3 · Cited by 38
MiR-181c-5p ameliorates learning and memory in sleep-deprived mice via HMGB1/TLR4/NF-κB pathway
HU, Y., HU, C., YIN, J., ZHONG, J., DENG, Y., & YANG, G. (2023) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765202320220750 · Cited by 4
Metadata
- Authors
- Xu, X., Piao, H., Aosai, F., Zeng, X., Cheng, J., Cui, Y., Li, J., Ma, J., Piao, H., Jin, X., & Piao, L.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2020-10-19
- Volume
- 177
- Issue
- 22
- Pages
- 5224-5245
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W3083948029
- Cited by
- 277
- References
- 70
- FWCI
- 8.52
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.